Who is this course for?
practising psychologists, psychiatrists, and other medical professionals
The Introduction to Psychedelic-assisted Therapy is a continuing education credited training course designed for practising psychologists, psychiatrists, and other medical professionals. The course is a prerequisite for the ATMA Advanced Psychedelic-assisted Therapy (PaT) Certification Program, and
Atma Journey
English
21 Hours
The Introduction to Psychedelic-assisted Therapy is a continuing education credited training course designed for practising psychologists, psychiatrists, and other medical professionals. The course is a prerequisite for the ATMA Advanced Psychedelic-assisted Therapy (PaT) Certification Program, and is accepting registrations every second month.
The course begins by redefining the psychiatric model from one of "chemical imbalance" to one rooted in the mind-body-spirit dynamic, and provides historical context for the development of psychedelic medicines. The didactic course material will cover various psychedelic medicines currently in use, including an emphasis on psilocybin, MDMA, LSD, iboga, ayahuasca, and ketamine. The course will also explore how psychedelic-assisted therapy can be integrated into and enhance existing therapeutic modalities, such as internal family systems (IFS), cognitive-behavioural therapy (CBT), somatic therapy, and eye movement desensitization and reprocessing (EMDR).
The program includes 12 lessons, 17 hours of video lectures, 4 hours of interactive Q&A, community platform membership and CE credits (valid in Canada). The training is designed to provide evidence-based tools to enhance current practice for practising social workers, counsellors, psychologists, psychiatrists and medical professionals.
practising psychologists, psychiatrists, and other medical professionals
Prerequisite for the ATMA Advanced Psychedelic-assisted Therapy (PaT) Certification Program
ATMA Journey Centers is an Alberta-based Canadian pioneer in psychedelic-assisted therapy, operating clinically supervised locations across Canada while offering comprehensive psychedelic-assisted therapy training programs (ATMA CENA) covering psilocybin, MDMA, and ketamine for healthcare professionals. With 740+ training alumni and 800+ community members, ATMA also operates a clinic network partnership program and Phase II psilocybin clinical trials with Health Canada approval.
practising psychologists, psychiatrists, and other medical professionals
Prerequisite for the ATMA Advanced Psychedelic-assisted Therapy (PaT) Certification Program
Format: Live Classes. Time commitment: 21 Hours.
The listed price is $1,600. Confirm the latest tuition, fees, and payment options with [object Object].
Accreditation note: CE credits (valid in Canada). Confirm credential eligibility directly with the provider before enrolling.
The current listing status is No New Dates. Use the provider website for the latest enrollment status.
By Instituto Alma Viva
Same course category
Explore the first MEC-approved Postgraduate Course in Psychedelic-Assisted Psychotherapy in Brazil, designed for psychologists and psychiatrists. Learn cutting-edge therapeutic techniques, gain practical experience, and contribute to pioneering research.
Source lists: 360 hours
Delivery: Online + São Paulo, Brazil
No medicine self-experience listed
By Phoenix Academy
Same course category
Online course in clinical psychedelic therapy covering preparation, dosing, safety, integration, and work with co-therapists and clients. Includes videos, interactive content, quizzes, and course documents.
Source lists: Estimated 100 hours
Delivery: Online
By Alma Institute
Shares course skills and categories
Psychotherapy skill topic focused on courses related to psychedelic therapy, integration, facilitation, ethics, and trauma-informed care. It is used to group courses that cover psychotherapy-adjacent practice and clinical topics.
Next cohort: Jul 13, 2026